|
1
|
Mazzaferro V, Regalia E, Doci R, et al:
Liver transplantation for the treatment of small hepatocellular
carcinoma in patients with cirrhosis. N Engl J Med. 334:693–699.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee SG, Hwang S, Moon DB, et al: Expanded
indication criteria of living donor liver transplantation for
hepatocellular carcinoma at one large-volume center. Liver Tanspl.
14:935–945. 2008.PubMed/NCBI
|
|
3
|
Sugawara Y, Tamura S and Makuuchi M:
Living donor liver transplantation for hepatocellular carcinoma:
Tokyo University series. Dig Dis. 25:310–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ito T, Takada Y, Ueda M, et al: Expansion
of selection criteria for patients with hepatocellular carcinoma in
living donor liver transplantation. Liver Transpl. 13:1637–1644.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takada Y, Ito T, Ueda M, et al: Living
donor liver transplantation for patients with HCC exceeding the
Milan criteria: a proposal of expanded criteria. Dig Dis.
25:299–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soejima Y, Taketomi A, Yoshizumi T, et al:
Extended indication for living donor liver transplantation in
patients with hepatocellular carcinoma. Transplantation.
83:893–899. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taketomi A, Sanefuji K, Soejima Y, et al:
Impact of des-gamma-carboxy prothrombin and tumor size on the
recurrence of hepatocellular carcinoma after living donor liver
transplantation. Transplantation. 87:531–537. 2009. View Article : Google Scholar
|
|
8
|
Shirabe K, Taketomi A, Morita K, et al:
Comparative evaluation of expanded criteria for patients with
hepatocellular carcinoma beyond the Milan criteria undergoing
living-related donor liver transplantation. Clin Transplant.
25:E491–E498. 2011. View Article : Google Scholar
|
|
9
|
Furukawa H, Shimamura T, Suzuki T, et al:
Liver transplantation for hepatocellular carcinoma: the Japanese
experience. J Hepatobiliary Pancreat Surg. 17:533–538. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mazzaferro V, Llovet JM, Miceli R, et al:
Predicting survival after liver transplantation in patients with
hepatocellular carcinoma beyond the Milan criteria: a
retrospective, exploratory analysis. Lancet Oncol. 10:35–43. 2009.
View Article : Google Scholar
|
|
11
|
Yao FY, Ferrell L, Bass NM, et al: Liver
transplantation for hepatocellular carcinoma: expansion of the
tumor size limits does not adversely impact survival. Hepatology.
33:1394–1403. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kobayashi S, Matsui O, Gabata T, et al:
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic
acid-enhanced magnetic resonance imaging findings of borderline
lesions at high risk for progression to hypervascular classic
hepatocellular carcinoma. J Comput Asist Tomogr. 35:181–186. 2011.
View Article : Google Scholar
|
|
13
|
Kobayashi S, Matsui O, Gabata T, et al:
Intranodular signal intensity analysis of hypovascular high-risk
borderline lesions of HCC that illustrate multi-step
hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.
Eur J Radiol. 81:3839–3845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyayama S, Matsui O, Yamashiro M, et al:
Detection of hepatocellular carcinoma by CT during arterial
portography using a cone-beam CT technology: comparison with
conventional CTAP. Abdom Imaging. 34:502–506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kitao A, Zen Y, Matsui O, Gabata T and
Nakanuma Y: Hepatocarcinogenesis: multistep changes of drainage
vessels at CT during arterial portography and hepatic arteriography
- radiologic-pathologic correlation. Radiology. 252:605–614. 2009.
View Article : Google Scholar
|
|
16
|
Miyayama S, Yamashiro M, Okuda M, et al:
Detection of corona enhancement of hypervascular hepatocellular
carcinoma by C-arm dual-phase cone-beam CT during hepatic
arteriography. Cardiovasc Intervent Radiol. 34:81–86. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsui O, Kobayashi S, Sanada J, et al:
Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation
(angiography-assisted CT) with special reference to multi-step
hepatocarcinogenesis. Abdom Imaging. 36:264–272. 2011. View Article : Google Scholar
|
|
18
|
Mazzocca A, Dituri F, Lupo L, Quaranta M,
Antonaci S and Giannelli G: Tumor-secreted lysophostatidic acid
accelerates hepatocellular carcinoma progression by promoting
differentiation of peritumoral fibroblasts in myofibroblasts.
Hepatology. 54:920–930. 2011. View Article : Google Scholar
|
|
19
|
Okabe H, Beppu T, Hayashi H, et al:
Hepatic stellate cells may relate to progression of intrahepatic
cholangiocarcinoma. Ann Surg Oncol. 16:2555–2564. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Manual. 6th edition. Springer-Verlag; New York:
pp. 4352002
|
|
21
|
United Network for Organ Sharing: Policy
3.6. www.unos.orgurisimplewww.unos.org. Accessed September
8, 2002
|
|
22
|
Urata K, Kawasaki S, Matsunami H, et al:
Calculation of child and adult standard liver volume for liver
transplantation. Hepatology. 21:1317–1321. 1995.PubMed/NCBI
|
|
23
|
Authors not listed. Terminology of nodular
hepatocellular lesions. International Working Party Hepatology.
22:101–105. 1995.
|
|
24
|
Hirohashi S, Ishak KG, Kojiro M, et al:
Hepatocellular carcinoma. Pathology and Genetics of Tumours of the
Digestive System. Hamilton SR and Aaltonen LA: IARC Press; Lyon:
pp. 159–172. 2000
|
|
25
|
Hayashi M, Matsui O, Ueda K, et al:
Correlation between the blood supply and grade of malignancy of
hepatocellular nodules associated with liver cirrhosis: evaluation
by CT during intraarterial injection of contrast medium. AJR Am J
Roentgenol. 172:969–976. 1999. View Article : Google Scholar
|
|
26
|
Chapman WC, Majella Doyle MB, Stuart JE,
et al: Outcomes of neoadjuvant transarterial chemoembolization to
downstage hepatocellular carcinoma before liver transplantation.
Ann Surg. 248:617–625. 2008.
|
|
27
|
Ravaioli M, Grazi GL, Piscaglia F, et al:
Liver transplantation for hepatocellular carcinoma: results of
down-staging in patients initially outside the Milan selection
criteria. Am J Transplant. 8:2547–2557. 2008. View Article : Google Scholar
|
|
28
|
Yao FY, Kerlan RK Jr, Hirose R, et al:
Excellent outcome following down-staging of hepatocellular
carcinoma prior to liver transplantation: an intention-to-treat
analysis. Hepatology. 48:819–827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serini G and Gabbiani G: Mechanisms of
myofibroblast activity and phenotypic modulation. Exp Cell Res.
250:273–283. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier
C and Brown RA: Myofibroblasts and mechano-regulation of connective
tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sappino AP, Skalli O, Jackson B, Schürch W
and Gabbiani G: Smooth muscle differentiation in stromal cells of
malignant and non-malignant breast tissues. Int J Cancer.
41:707–712. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Di Tommaso L, Pasquinelli G and Damiani S:
Smooth muscle cell differentiation in mammary stromo-epithelial
lesions with evidence of a dual origin: stromal myofibroblasts and
myoepithelial cells. Histopathology. 42:448–456. 2003.PubMed/NCBI
|
|
33
|
Orimo A, Gupta PB, Sgroi DC, et al:
Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12
secretion. Cell. 121:335–348. 2005. View Article : Google Scholar
|
|
34
|
Qiu W, Hu M, Sridhar A, et al: No evidence
of clonal somatic genetic alterations in cancer-associated
fibroblasts from human breast and ovarian carcinomas. Nat Genet.
40:650–655. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haviv I, Polyak K, Qiu W, Hu M and
Campbell I: Origin of carcinoma associated fibroblasts. Cell Cycle.
8:589–595. 2009. View Article : Google Scholar
|
|
36
|
Yang MH, Chen CL, Chau GY, Chiou SH, Su
CW, Chou TY, et al: Comprehensive analysis of the independent
effect of twist and snail in promoting metastasis of hepatocellular
carcinoma. Hepatology. 50:1464–1474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo C, Liu QG, Yang W, Zhang ZL and Yao
YM: Relation among p130Cas, E-cadherin and beta-catenin expression,
clinicopathologic significance and prognosis in human
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int.
7:490–496. 2008.
|
|
38
|
Korita PV, Wakai T, Shirai Y, et al:
Overexpression of osteopontin independently correlates with
vascular invasion and poor prognosis in patients with
hepatocellular carcinoma. Hum Pathol. 39:1777–1783. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhan DQ, Wei S, Liu C, et al: Reduced
N-cadherin expression is associated with metastatic potential and
poor surgical outcomes of hepatocellular carcinoma. J Gastroenterol
Hepatol. 27:173–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Seo DD, Lee HC, Kim HJ, et al: Neural
cadherin overexpression is a predictive marker for early
postoperative recurrence in hepatocellular carcinoma patients. J
Gastroenterol Hepatol. 23:1112–1118. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu L, Lau SH, Tzang CH, et al: Association
of Vimentin overexpression and hepatocellular carcinoma metastasis.
Oncogene. 23:298–302. 2004.PubMed/NCBI
|
|
42
|
Pan TL, Wang PW, Huang CC, Yeh CT, Hu TH
and Yu JS: Network analysis and proteomic identification of
vimentin as a key regulator associated with invasion and metastasis
in human hepatocellular carcinoma cells. J Proteomics.
75:4676–4692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miyoshi A, Kitajima Y, Kido S, et al:
Snail accelerates cancer invasion by upregulating MMP expression
and is associated with poor prognosis of hepatocellular carcinoma.
Br J Cancer. 92:252–258. 2005.PubMed/NCBI
|
|
44
|
Shah SA, Tan JC, McGilvray ID, et al: Does
microvascular invasion affect outcomes after liver transplantation
for HCC? A histopathological analysis of 155 consecutive explants.
J Gastrointest Surg. 11:464–471. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zheng SS, Xu X, Wu J, et al: Liver
transplantation for hepatocellular carcinoma: Hangzhou experiences.
Transplantation. 85:1726–1732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mergental H, Adam R, Ericzon BG, et al:
Liver transplantation for unresectable hepatocellular carcinoma in
normal livers. J Hepatol. 57:297–305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sandhu L, Sandroussi C, Guba M, et al:
Living donor liver transplantation versus deceased donor liver
transplantation for hepatocellular carcinoma: comparable survival
and recurrence. Liver Transpl. 18:315–322. 2012. View Article : Google Scholar
|
|
48
|
Chan SC, Fan ST, Chok KS, et al: Survival
advantage of primary liver transplantation for hepatocellular
carcinoma within the up-to-7 criteria with microvascular invasion.
Hepatol Int. Oct 21–2011.(Epub ahead of print).
|
|
49
|
Chou CT, Chen RC, Lee CW, Ko CJ, Wu HK and
Chen YL: Prediction of microvascular invasion of hepatocellular
carcinoma by pre-operative CT imaging. Br J Radiol. 85:778–783.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chandarana H, Robinson E, Hajdu CH,
Drozhinin L, Babb JS and Taouli B: Microvascular invasion in
hepatocellular carcinoma: is it predictable with pretransplant MRI?
AJR Am J Roentgenol. 196:1083–1089. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kim KA, Kim MJ, Jeon HM, et al: Prediction
of microvascular invasion of hepatocellular carcinoma: usefulness
of peritumoral hypointensity seen on gadoxetate disodium-enhanced
hepatobiliary phase images. J Magn Reson Imaging. 35:629–634. 2012.
View Article : Google Scholar
|
|
52
|
Adler M, De Pauw F, Vereerstraeten P, et
al: Outcome of patients with hepatocellular carcinoma listed for
liver transplantation within the Eurotransplant allocation system.
Liver Transpl. 14:526–533. 2008. View Article : Google Scholar
|
|
53
|
Chen JW, Kow L, Verran DJ, et al: Poorer
survival in patients whose explanted hepatocellular carcinoma (HCC)
exceeds Milan or UCSF Criteria. An analysis of liver
transplantation in HCC in Australia and New Zealand. HPB (Oxford).
11:81–89. 2009. View Article : Google Scholar
|
|
54
|
D’Amico F, Schwartz M, Vitale A, et al:
Predicting recurrence after liver transplantation in patients with
hepatocellular carcinoma exceeding the up-to-seven criteria. Liver
Transpl. 15:1278–1287. 2009.
|
